Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.
Nakabori T, Higashi S, Abe Y, Mukai K, Ikawa T, Konishi K, Maeda N, Nakanishi K, Hasegawa S, Wada H, Ohkawa K. Nakabori T, et al. Among authors: nakanishi k. Curr Oncol. 2024 Mar 15;31(3):1543-1555. doi: 10.3390/curroncol31030117. Curr Oncol. 2024. PMID: 38534950 Free PMC article.
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers.
Kimura H, Ohkawa K, Miyazaki M, Sakakibara M, Imanaka K, Tamura T, Sueyoshi H, Takada R, Fukutake N, Uehara H, Ashida R, Ioka T, Nakazawa T, Nakanishi K, Katayama K. Kimura H, et al. Among authors: nakanishi k. Hepatol Int. 2017 Jan;11(1):105-114. doi: 10.1007/s12072-016-9771-0. Epub 2016 Oct 20. Hepatol Int. 2017. PMID: 27766479
Prognostic Factors for Patients With a Large Number of Hepatocellular Carcinoma Nodules.
Abe Y, Ohkawa K, Sakakibara M, Nawa T, Fukutake N, Ikezawa K, Takada R, Kusakabe A, Imai T, Nakanishi K, Tabuchi T, Hikita H, Sakamori R, Tatsumi T, Takehara T, Katayama K. Abe Y, et al. Among authors: nakanishi k. J Clin Med Res. 2020 Jan;12(1):26-35. doi: 10.14740/jocmr4032. Epub 2020 Jan 6. J Clin Med Res. 2020. PMID: 32010419 Free PMC article.
Whole-body MRI: detecting bone metastases from prostate cancer.
Nakanishi K, Tanaka J, Nakaya Y, Maeda N, Sakamoto A, Nakayama A, Satomura H, Sakai M, Konishi K, Yamamoto Y, Nagahara A, Nishimura K, Takenaka S, Tomiyama N. Nakanishi K, et al. Jpn J Radiol. 2022 Mar;40(3):229-244. doi: 10.1007/s11604-021-01205-6. Epub 2021 Oct 25. Jpn J Radiol. 2022. PMID: 34693502 Free PMC article. Review.
Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography.
Kawada N, Ohkawa K, Tanaka S, Matsunaga T, Uehara H, Ioka T, Takano Y, Takakura R, Imanaka K, Tamai C, Kawaguchi T, Tomita Y, Nakanishi K, Katayama K. Kawada N, et al. Among authors: nakanishi k. Hepatol Res. 2010 Sep;40(9):930-6. doi: 10.1111/j.1872-034X.2010.00697.x. Hepatol Res. 2010. PMID: 20887598
Impact of magnetic resonance imaging-related geometric distortion of dose distribution in fractionated stereotactic radiotherapy in patients with brain metastases.
Ohira S, Suzuki Y, Washio H, Yamamoto Y, Tateishi S, Inui S, Kanayama N, Kawamata M, Miyazaki M, Nishio T, Koizumi M, Nakanishi K, Konishi K. Ohira S, et al. Among authors: nakanishi k. Strahlenther Onkol. 2024 Jan;200(1):39-48. doi: 10.1007/s00066-023-02120-7. Epub 2023 Aug 17. Strahlenther Onkol. 2024. PMID: 37591978
2,943 results